Company
CardieX Limited
Headquarters: Sydney, NSW, Australia
CEO: Mr. Craig R. Cooper
Market Cap
A$21.7 Million
AUD as of Jan. 1, 2024
US$14.8 Million
CardieX Limited Categories
Australia Healthcare Medical DevicesAustralia Healthcare Australia Medical Devices
Top Competitors by Market Capitalization
Industry: Medical Devices
| Company | Market Cap (USD) |
|---|---|
| Abbott | $192.67 B |
| Stryker Corporation | $113.24 B |
| Medtronic | $111.60 B |
| Boston Scientific Corporation | $85.22 B |
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $49.33 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
CardieX Limited designs, manufactures, and markets medical devices for use in cardiovascular health management in the Americas, Europe, and the Asia Pacific. The company develops, markets, and distributes XCEL and Oscar 2 medical devices for the management and diagnosis of hypertension, cardiovascular disease, and other related vascular disorders. It also develops and markets home health devices, wearables, and consumer and medical health apps under the CONNEQT name. In addition, the company provides medical devices for measuring arterial stiffness and central blood pressure waveforms. It serves hospitals, clinics, research institutions and pharmaceutical companies. The company was formerly known as AtCor Medical Holdings Limited and changed its name to CardieX Limited in June 2018. CardieX Limited was founded in 1994 and is based in Sydney, Australia.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
CardieX Limited has the following listings and related stock indices.
Stock: ASX: CDX wb_incandescent